FDC Ltd. — Investor Relations & Filings
FDC Ltd. specializes in the manufacture and marketing of active ingredients and finished dosage forms. The company maintains a diverse portfolio across therapeutic segments, including anti-infectives, gastrointestinals, ophthalmics, and vitamins. It is widely recognized for its leadership in the oral rehydration salts (ORS) market with its flagship brand, Electral. Other notable products include Zifi, a broad-spectrum antibiotic, and Enerzal, a balanced energy drink. The organization operates multiple manufacturing facilities certified by global regulatory bodies and serves a broad range of markets. The company focuses on research and development to enhance its formulation capabilities and expand its footprint through strategic exports and partnerships.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Shareholders meeting | 2026-05-09 | English | |
| Corrigendum to Postal Ballot Notice dated April 21, 2026 | 2026-05-09 | English | |
| Disclosure under SEBI Takeover Regulations | 2026-05-07 | English | |
| Updates | 2026-04-24 | English | |
| Copy of Newspaper Publication | 2026-04-24 | English | |
| Shareholders meeting | 2026-04-22 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 44643950 | Shareholders meeting | 2026-05-09 | English | ||
| 44722756 | Corrigendum to Postal Ballot Notice dated April 21, 2026 | 2026-05-09 | English | ||
| 42492038 | Disclosure under SEBI Takeover Regulations | 2026-05-07 | English | ||
| 36126957 | Updates | 2026-04-24 | English | ||
| 36126965 | Copy of Newspaper Publication | 2026-04-24 | English | ||
| 42178664 | Shareholders meeting | 2026-04-22 | English | ||
| 42190539 | General Updates | 2026-04-21 | English | ||
| 42208175 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | 2026-04-10 | English | ||
| 42165679 | Trading Window | 2026-03-26 | English | ||
| 42215546 | Updates | 2026-03-20 | English | ||
| 42173994 | Change in Director(s) | 2026-03-18 | English | ||
| 42162408 | Disclosure under SEBI Takeover Regulations | 2026-02-19 | English | ||
| 42162551 | Disclosure under SEBI Takeover Regulations | 2026-02-19 | English | ||
| 42189419 | General Updates | 2026-02-17 | English | ||
| 42226692 | General Updates | 2026-02-10 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Curevac
A biopharmaceutical company developing therapies based on m…
|
CVAC | NL | Manufacturing |
|
CureVac N.V.
A biopharmaceutical company developing mRNA-based medicines…
|
CVAC | US | Manufacturing |
|
CURIS INC
Biotechnology company developing and commercializing therap…
|
CRIS | US | Manufacturing |
|
Curis Lifesciences Limited
Researches and produces therapeutic formulations for divers…
|
CURIS | IN | Manufacturing |
|
Curocell Inc.
A clinical-stage biotech developing CAR-T therapies for blo…
|
372320 | KR | Manufacturing |
|
Cutia Therapeutics
R&D-driven biopharma specializing in developing and commerc…
|
2487 | HK | Manufacturing |
|
Cybin Inc.
Clinical-stage biopharma developing breakthrough neuropsych…
|
HELP | CA | Manufacturing |
|
CYBIN INC.
A late-stage neuropsychiatry company developing psychedelic…
|
CYBN | CA | Manufacturing |
|
Cyclerion Therapeutics, Inc.
Develops personalized biofeedback therapies for treatment-r…
|
CYCN | US | Manufacturing |
|
Cyfuse Biomedical K.K.
Develops scaffold-free bio 3D printing technology for tissu…
|
4892 | JP | Manufacturing |
FDC Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/60812/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=60812 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=60812 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=60812 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 60812}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for FDC Ltd. (id: 60812)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.